The examples of successful application of anti-ErbB antibodies in cancer treatment includecetuximab (anti-EGFR) in head and neck cancer therapy andtrastuzumab (anti-HER2) in breast cancer treatment. This evidence concerns the gene EGFR and breast carcinoma.